Other
No interventions need to be specified for this study
No interventions need to be specified for this study is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(1)
Other(1)
Detailed Status
Not yet recruiting2
unknown1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Trials by Status
unknown125%
completed125%
not_yet_recruiting250%
Recent Activity
0 active trials
Showing 4 of 4
Clinical Trials (4)
Showing 4 of 4 trials
NCT07285174
Shanghai Lymphoma Clinical Cohort
NCT06573099
A Real-World Study on Extranodal Lymphoma
NCT06549361
A Retrospective Study on Extranodal DLBCL
NCT05907447
A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4